| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |